Please login to the form below

Not currently logged in
Email:
Password:

sipuleucel-T

This page shows the latest sipuleucel-T news and features for those working in and with pharma, biotech and healthcare.

Sanofi forges $1.5bn cancer partnership with BioNTech

Sanofi forges $1.5bn cancer partnership with BioNTech

Earlier this year, BioNTech also forged a $360m alliance with Eli Lilly for the discovery of novel tumour targets and the development of T cell receptor (TCR) therapies for multiple cancer ... s cancer vaccine Provenge (sipuleucel-T).

Latest news

More from news
Approximately 2 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Corporate acquisition. 400. Dendreon/ Valeant Pharmaceuticals. PROVENGE (sipuleucel-T) and other assets - prostate cancer.

  • Pharma deals in February 2015 Pharma deals in February 2015

    This month saw the deadline, highlighted in January's Deal Watch, for Valeant to acquire Dendreon, and more specifically the dendritic cell, prostate cancer vaccine Provenge (sipuleucel-T), come and go. ... NICE has concluded that the price is “too

  • Pharma deals during January 2015 Pharma deals during January 2015

    The lead candidate CM-CS1 is phase 1 ready and the acquisition brings access to 2 CAR T-cell programmes in preclinical development plus the allogeneic T-cell platform allowing the ... Staying with immuno-oncology, an acquisition in the making is the

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...